移植甲状旁腺激素处理的跟腱促进大鼠半月板缺损模型中的半月板再生
本研究在大鼠半月板缺损模型中,将注射甲状旁腺激素(PTH)(1-34)的跟腱移植到内侧半月板缺损处,并与注射磷酸盐缓冲液组比较。体外实验显示PTH处理的跟腱来源细胞阿尔新蓝染色更好,PTH1R、Col2a1、Sox9和RUNX2显著上调(P<.05)。体内实验显示PTH组再生半月板覆盖更明显、关节软骨退变进展更少,组织学评分在4周和8周均优于未处理组(P<.05)。
要点
- PTH(1-34)可诱导大鼠跟腱来源细胞软骨形成,相关基因PTH1R、Col2a1、Sox9、RUNX2显著上调(P<.05)。
- 在大鼠内侧半月板缺损模型中,移植PTH处理的跟腱可促进半月板再生并保留膝关节软骨。
- PTH处理组再生半月板的组织学评分在术后4周和8周均显著高于未处理组(P<.05)。
核心结论
- PTH(1-34)可诱导大鼠跟腱形成软骨,移植PTH(1-34)处理的跟腱在大鼠半月板缺损模型中诱导半月板再生并保留膝关节软骨。
- 宏观上PTH组再生半月板覆盖更大,组织学上PTH处理跟腱移植大鼠的再生半月板软骨基质含量更高。
- PTH(1-34)刺激跟腱来源细胞促进软骨分化。
研究设计与样本
- 受控实验室研究。
- 体外:大鼠跟腱来源细胞分别在有或无PTH条件下培养28天,阿尔新蓝染色评估软骨分化,培养14天和28天后用实时定量聚合酶链反应评估基因表达。
- 体内:大鼠跟腱注射PTH后移植到内侧半月板缺损处,术后4周和8周对再生半月板及胫骨平台软骨退变进行宏观和组织学评估。
主要发现
- 体外:PTH处理细胞阿尔新蓝染色优于对照(正常培养基)组,PTH1R、Col2a1、Sox9和RUNX2在PTH处理细胞中显著上调(P<.05)。
- 体内宏观:PTH组再生半月板覆盖较磷酸盐缓冲液注射组更明显,关节软骨退变进展更少。
- 体内组织学:甲苯胺蓝染色显示PTH注射组织在4周和8周出现异染性,异染区域II型胶原免疫染色阳性。
- PTH处理组再生半月板组织学评分在4周和8周均高于未处理组(P<.05)。
临床怎么用
- 作者认为,使用PTH注射的自体肌腱移植物进行半月板移植可能通过刺激跟腱来源细胞软骨分化来促进半月板再生并阻止软骨退变进展。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autologous tendon grafts are used for meniscal reconstruction of surgically removed knee joint meniscus. However, as meniscal reconstruction cannot prevent the progression of cartilage degeneration, additional procedures that confer meniscus-like histological properties to the transplanted tendon are required for improved outcomes. HYPOTHESES: Parathyroid hormone (PTH)(1-34) induces cartilage formation in the rat tendon, and transplantation of PTH-treated tendon promotes meniscal regeneration. STUDY DESIGN: Controlled laboratory study. METHODS: Rat Achilles tendon-derived cells were cultured with or without PTH for 28 days and stained with Alcian blue to determine chondrogenic differentiation. After 14 and 28 days of incubation, gene expression was assessed using quantitative real-time polymerase chain reaction. In an in vivo study, rat Achilles tendon was injected with PTH and then transplanted onto a medial meniscal defect. Macroscopic and histological assessments of the regenerated meniscus and of cartilage degeneration in the tibial plateau were performed at 4 and 8 weeks after surgery. RESULTS: In vitro, PTH-treated cells showed better staining with Alcian blue than the control (normal medium) group. PTH1R, Col2a1, Sox9, and RUNX2 were significantly upregulated in PTH-treated cells (P < .05). Macroscopically, the in vivo results revealed more prominent meniscal coverage and lesser progression of articular cartilage degeneration in the PTH group than in the phosphate-buffered saline-injected group. Histologically, toluidine blue staining revealed metachromasia in the PTH-injected tissue at 4 and 8 weeks. The PTH-treated regenerated meniscus showed positive immunostaining for type II collagen in the area exhibiting metachromasia. Moreover, PTH-treated tendon had an enhanced histological score compared with the untreated group at 4 and 8 weeks (P < .05). CONCLUSION: PTH(1-34) induced cartilage formation in the rat tendon. Transplantation of PTH(1-34)-treated Achilles tendon in a rat meniscal defect model induced meniscal regeneration and preserved knee articular cartilage. Macroscopically, PTH groups showed a greater coverage of the regenerated meniscus. Histologically, the regenerated meniscus had higher cartilaginous matrix content in rats transplanted with PTH-treated tendons. PTH(1-34) stimulated tendon-derived cells to promote chondrogenic differentiation. CLINICAL RELEVANCE: Meniscal transplantation using PTH-injected autologous tendon grafts might promote meniscal regeneration and prevent progression of cartilage degeneration by stimulating chondrogenic differentiation of tendon-derived cells.
引用
- Nishino K, Hashimoto Y, Nishida Y, et al. Transplantation of Parathyroid Hormone-Treated Achilles Tendon Promotes Meniscal Regeneration in a Rat Meniscal Defect Model. Am J Sports Med. 2022. PMID: 35914290. doi:10.1177/03635465221112954
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。